Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Large B-Cell, Diffuse × Bortezomib × Clear all

Phase

Phase 2 12 Phase 1 9 Phase 1/2 5 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 79 Recurrence 9 Neoplasms, Plasma Cell 9 Immunoglobulin Light-chain Amyloidosis 6 Paraproteinemias 4 Neoplasms 4 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Immunoproliferative Disorders 2 Hematologic Diseases 2 Disease Progression 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Vascular Diseases 1 Sezary Syndrome 1 Sarcoma, Myeloid 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Pathologic Complete Response 1 Neoplasms by Histologic Type 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Immune System Diseases 1 Hemostatic Disorders 1 Hemorrhagic Disorders 1 Cholangiocarcinoma 1

Interventions

Rituximab 61 Cyclophosphamide 43 Doxorubicin 38 Vincristine 37 Prednisone 33 Etoposide 17 Radiotherapy 13 Gemcitabine 13 Lenalidomide 11 Cytarabine 11 Peripheral Blood Stem Cell Transplantation 10 Filgrastim 10 Oxaliplatin 9 Carmustine 9 VAP-cyclo protocol 8 Prednisolone 8 Melphalan 8 Mitoxantrone 5 Methotrexate 5 Ifosfamide 5 Bleomycin 5 polatuzumab vedotin 4 R-CHOP protocol 4 Injections 4 Cyclosporine 4 pegfilgrastim 3 ibritumomab tiuxetan 3 Vindesine 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01324596 2016-04-15

REMoDL-B

University Hospital Southampton NHS Foundation Trust

Phase 3 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡